Bilcare GCS Expands Phase III Clinical Trial Service Capabilities

As part of its commitment to providing its customers with comprehensive services that span the entire clinical supply chain, Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial supplies and services, has enhanced its global Phase III capabilities.  Its latest Phase III investments include the upgrade of its Kalish large-scale bottling line at its U.S.

More: continued here

Filed under: Pharma Industry on September 8th, 2008